Skip to content

Hepatitis C Virus Fibrosis Assessment (Serum/Plasma) – FibroSure

Published: August 9, 2026Updated: August 16, 2026

This test measures liver fibrosis, a condition where scar tissue builds up in your liver due to chronic hepatitis C infection. It helps doctors assess how much damage your liver has sustained and guides treatment decisions.

Quick summary

["A fibrosis test helps determine liver health and treatment planning for hepatitis C."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
48796-7
Short code
HCV FibroSURE Pnl SerPl
Synonyms
HCV FibroSURE Pnl SerPl
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
86803
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The FibroSure test uses a specialized blood test to evaluate the degree of fibrosis (scarring) in your liver caused by hepatitis C. It measures a biomarker that reflects the structural changes in liver tissue, helping to distinguish between mild, moderate, and advanced fibrosis.

Why Is This Test Important?

Fibrosis progression can lead to serious liver complications, including cirrhosis and liver failure. This test helps your healthcare provider monitor liver health, tailor treatment plans, and prevent complications by identifying early signs of scarring.

How Is the Test Performed?

A blood sample is drawn from a vein in your arm. The serum or plasma is then analyzed using a specialized method to detect the fibrosis marker. Results are compared to a standardized scale to assess liver damage.

What Are the Next Steps?

Based on the test results, your doctor may recommend antiviral treatment, lifestyle changes, or monitoring. If fibrosis is advanced, additional tests or interventions may be needed to manage liver health.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Chronic hepatitis C can cause progressive liver damage, including fibrosis. Early detection of fibrosis helps prevent complications like cirrhosis, liver cancer, and liver failure. This test provides a non-invasive way to assess liver health and guide treatment decisions, ensuring better outcomes for long-term management of hepatitis C.

Short name

FibroSure HCV Fibrosis Test

Frequently asked questions

What does a positive or abnormal result mean?
An abnormal result suggests the presence of fibrosis, meaning your liver has developed scar tissue. This does not necessarily mean you have advanced liver disease, but it indicates the need for closer monitoring or treatment adjustments to slow progression.
How long does it take to get results?
Results are typically available within 1–3 business days, depending on your laboratory. Your healthcare provider will discuss the findings with you during your follow-up visit.
Can I eat or drink before this test?
You may eat and drink normally before the test, as it is a blood draw. However, follow any specific instructions your doctor or lab provides for optimal results.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy